Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond the shunt: Divergent insights from hyperoxia testing and contrast echocardiography in adults with pulmonary hypertension.

Physiological reports·2025
Same author

[Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)].

Revue des maladies respiratoires·2025
Same author

[Low-dose methotrexate: Indications and side effects, particularly in cases of diffuse interstitial pneumonia].

Revue des maladies respiratoires·2024
Same author

[Primary open angle glaucoma and sleep apnea syndrome: A review of the literature].

Journal francais d'ophtalmologie·2024
Same author

Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

[Fibroblast growth factor (FGF) endocrines and pulmonary fibrogenesis].

Revue des maladies respiratoires·2023

Related Experiment Videos

Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema.

D Goven1, A Boutten, V Leçon-Malas

  • 1Inserm U700, Faculté de Médecine Paris 7, Site X Bichat, BP416, 75870 Paris Cedex 18, France.

Thorax
|June 19, 2008
PubMed
Summary

In pulmonary emphysema, decreased levels of the Nrf2 protein and increased Bach1 and Keap1 disrupt antioxidant defenses. This altered equilibrium in alveolar macrophages contributes to disease progression and reduced antioxidant protein expression.

Related Experiment Videos

Area of Science:

  • Pulmonary Medicine
  • Cellular Biology
  • Oxidative Stress Research

Background:

  • Oxidative stress is implicated in smoking-related pulmonary emphysema.
  • Antioxidant protein expression (HO-1, GPX2, NQO1) is regulated by transcription factors Nrf2, Keap1, and Bach1.
  • Altered expression of these transcription factors may contribute to decreased antioxidant defenses in emphysema.

Purpose of the Study:

  • To investigate the expression and subcellular localization of Nrf2, Keap1, and Bach1 in alveolar macrophages from patients with and without emphysema.
  • To determine if altered transcription factor levels correlate with reduced antioxidant protein expression in emphysema.
  • To explore the role of the Nrf2/Keap1/Bach1 balance in the pathophysiology of emphysema.

Main Methods:

  • Western blot, immunohistochemistry, and confocal microscopy were used to analyze protein levels and localization.
  • Lung tissue and alveolar macrophages from non-smokers and smokers (with/without emphysema) were examined.
  • Silencing RNA (siRNA) experiments were conducted in vitro to confirm gene expression relationships.

Main Results:

  • Nrf2 protein levels were significantly decreased in emphysema patients' lung tissue and alveolar macrophages.
  • Bach1 and Keap1 levels were increased in emphysema patients.
  • Decreased Nrf2 correlated with reduced HO-1, GPX2, and NQO1 expression and increased markers of oxidative damage, indicating an altered Nrf2/Keap1-Bach1 equilibrium.

Conclusions:

  • The Nrf2/Keap1-Bach1 balance is disrupted in alveolar macrophages in pulmonary emphysema.
  • This disruption leads to a decreased cellular stress response and reduced antioxidant capacity.
  • Findings suggest potential therapeutic strategies targeting the restoration of this transcription factor equilibrium.